The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
Ann Intern Med
; 174(5): 633-640, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33524293
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Hepatic Encephalopathy
/
Portasystemic Shunt, Transjugular Intrahepatic
/
Rifaximin
/
Liver Cirrhosis
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Intern Med
Year:
2021
Document type:
Article